![](/img/cover-not-exists.png)
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Antonarakis, Emmanuel S., Tagawa, Scott T., Galletti, Giuseppe, Worroll, Daniel, Ballman, Karla, Vanhuyse, Marie, Sonpavde, Guru, North, Scott, Albany, Costantine, Tsao, Che-Kai, Stewart, John, Zaher,Volume:
35
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.72.4138
Date:
October, 2017
File:
PDF, 1018 KB
english, 2017